fda approval of tirzepatide for weight loss is approved Semaglutide vs. Tirzepatide: Which Treatment Right You? Choosing between tirzepatide clinical trial weight loss

These developments underscore the expanding arsenal of diabetes drugs available to clinicians

BPC-157 may also upregulate the expression of early growth response gene-1 (EGR-1), which is a growth factor with potential benefits for the nervous system, having been suggested to aid in early extracellular matrix (collagen) formation [5]

The GLP-1 biosimilars market is primarily driven by the rapidly increasing global prevalence of type 2 diabetes and obesity, rising demand for affordable biologic therapies, and the impending patent expirations of major originator GLP-1 drugs such as semaglutide and dulaglutide

Thank you Citizenmeds